(Q40744879)

23 September 2017

title

Cell cycle arrest is sufficient for p53-mediated tumor regression (English)

1 reference

23 September 2017

Dubrez L

1

1 reference

23 September 2017

Coll JL

2

1 reference

23 September 2017

Hurbin A

3

1 reference

23 September 2017

de Fraipont F

4

1 reference

23 September 2017

Lantejoul S

5

1 reference

23 September 2017

Favrot MC

6

1 reference

23 September 2017

publication date

1 November 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

8

1 reference

23 September 2017

issue

22

1 reference

23 September 2017

page(s)

1705-1712

1 reference

The approaching era of the tumor suppressor genes

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Suppression of human colorectal carcinoma cell growth by wild-type p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Genes involved in senescence and immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Replicative senescence: implications for in vivo aging and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

7 January 2021

Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

7 January 2021

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

7 January 2021

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

7 January 2021

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301592

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301592

1 reference

Dimensions Publication ID

23 September 2017

1016574889

0 references

1 reference